Total Funding
69
81
Total FundingPost-IPO Equity raised
Growth Score
-18 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
312
BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.
- William Bauta: CSOPast Role: BioAffinity Technologies, SVP of Research and Development
- Gordon Downie: Chief Medical OfficerPast Role: Titus, Director of the Lung Nodule Clinic and Interventional Pulmonology
About the Company
BioAffinity Technologies applies experience, intelligence and creativity to the global fight against cancer, the company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment.
The company uses technology that preferentially targets cancer cells and cell types indicative of a sick
condition to produce exclusive noninvasive diagnostic tests and cancer therapies. The business is engaged in the development of technologies that, in the future, will be able to diagnose, track, and treat a variety of cancers, including lung ailments.
BioAffinity Technologies was established in 2014 in San Antonio, Texas.
Women Led
